Company intelligence / Profile preview

HaploX Biotechnology Co., Ltd.

Shenzhen, Guangdong, Chinafacebook.com ↗

Ownership: Private
Development stage: Commercial

Overview

HaploX is a leading provider of genetic testing solutions specializing in gene sequencing, liquid biopsies, bioinformatics, and big data analytics. The company offers comprehensive genetic testing services for cancer management, including early screening, individualized drug guidance, prognosis monitoring, and drug resistance assessment.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Genetic TestingLiquid BiopsiesNext-Generation Sequencing
Industry: Molecular Diagnostics

Partnerships

Illumina

Beyond the preview

Go deeper on HaploX Biotechnology Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HaploX Biotechnology Co., Ltd..

Explore the full profile